Senores Pharmaceuticals Limited
Who owns it
The named holders and split shown here are as of 31 Mar 2026 — an earlier filing than the 30 Jun 2026 ownership trend below.
Promoters hold 45.8%, short of a majority — the public block is larger, led by other public holders at 36.8%.
Each block is that holder’s share of the company; counts are shareholder accounts, so one holder may hold several. As filed.
Little has moved since Sep 2024 — the promoter’s share shifted 0.05pp.
The public block is shown whole here — it’s a mix of funds, foreign investors, corporates and individuals, not one kind of holder. The register below names who’s in it; the split by category is on the treemap above.
Promoter’s share of the company at the first and latest quarters on record. Moves under 0.25pp show grey — at that size, rounding in the filing is as large as the move. 3% of the promoter holding is pledged.
This register is as of 31 Mar 2026 — an earlier filing than the 30 Jun 2026 ownership trend above.
24 holders name themselves in this filing — promoters, institutions and public holders.
Plus 49 further holders below 0.1%, 0.13% between them.
Ownership shown is promoter and public holding split by category, the named holders, and promoter pledge.
How it trades
Loading trading data…
Splits, bonuses and rights
No splits, bonuses, rights issues or other corporate actions are on record for Senores Pharmaceuticals Limited since Aug 2024 — as far back as our records are certified complete.
Shown from Aug 2024, as far back as we can certify the record complete; earlier actions are not listed. Scheduled dividends are listed ahead of their ex-date, and past dividend ex-dates from the same window when on record — a stock with none shown either paid none in that window or predates our records; never read the absence as Senores Pharmaceuticals Limited having paid none.
Fundamentals and valuation — we hold neither. The government share of public holding — not broken out separately.
Senores Pharmaceuticals Limited — a factual record of what it disclosed to the exchange and how its shares have traded, never advice. Every figure is dated to its filing; absence is stated, never shown as zero.